clinical trial · NCT05816070
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Bacterial Conjunctivitis
Acute Bacterial ConjunctivitisIVIEW-1201Ofloxacin Eye Drops
brief summary
A Phase 2, Multi-center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW-1201 (1.0% Povidone-Iodine) Gel Forming Ophthalmic Solution Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis
started
Jan 5, 2023
primary completion
Nov 13, 2023
completion
Oct 12, 2024
last updated
Dec 2, 2025
official title
A Phase II, Multi-Center, Randomized, Parallel Controlled Study to Evaluate the Clinical Efficacy and Safety of IVIEW 1201 Compared to Ofloxacin Eye Drops in the Treatment of Acute Bacterial Conjunctivitis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol